Welcome to LookChem.com Sign In|Join Free

CAS

  • or

20951-43-3

Post Buying Request

20951-43-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

20951-43-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 20951-43-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,9,5 and 1 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 20951-43:
(7*2)+(6*0)+(5*9)+(4*5)+(3*1)+(2*4)+(1*3)=93
93 % 10 = 3
So 20951-43-3 is a valid CAS Registry Number.

20951-43-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-bromo-4-methylsulfonylphenol

1.2 Other means of identification

Product number -
Other names 2-bromo-4-methanesulfonylphenol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:20951-43-3 SDS

20951-43-3Upstream product

20951-43-3Relevant articles and documents

PROCESS FOR THE PREPARATION OF BROMODOMAIN INHIBITOR

-

Paragraph 0217-0218; 0224-0225; 0027-0228; 0267-0272, (2020/02/17)

The present invention provides processes of synthesis and purification of a bromodomain inhibitor, Compound 1, which compound includes crystalline forms, amorphous forms, solvates, and hydrates thereof. Embodiments of the disclosure relate to chemical syn

BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY

-

Paragraph 0140, (2017/07/14)

The present disclosure relates generally to compositions and methods of treating cancers, such as glioblastoma and non-Hodgkin's lymphomas, or other cancers in which the subject suffers from an advanced solid tumor, comprising the administration of a brom

Biaryl-propionic acid derivatives and their use as pharmaceuticals

-

Paragraph 0190; 0191, (2014/10/16)

The present invention relates to compounds of the formula I, wherein X, R, R1, R2, D, E1, E2, E3, E4, G1, G2, G3 and G4 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cath

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20951-43-3